Insider · CIK 0001602396

Hadas Nicole R.

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001602396

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-05-13	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−12K sh	$1.26	−$15.1K	651,243
2024-02-29	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−5,974 sh	$1.58	−$9,438.92	663,259
2024-02-27	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−7,411 sh	$1.52	−$11.3K	669,233
2024-01-31	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Legal Officer	AAward	+149K sh	—	—	676,644
2024-01-31	AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award	SVP, Chief Legal Officer	AAward	+224K sh	—	—	224,000
2023-05-25	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−63.2K sh	$1.22	−$77.3K	524,344
2023-05-24	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Legal Officer	AAward	+200K sh	—	—	587,530
2023-05-24	AKBAAkebia Therapeutics, Inc. · Employee Stock Option (Right to buy)A Award	SVP, Chief Legal Officer	AAward	+200K sh	—	—	200,000
2023-05-12	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Legal Officer	AAward	+100K sh	—	—	387,530
2023-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−5,333 sh	$0.88	−$4,679.707	295,231
2023-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−6,613 sh	$0.88	−$5,802.907	288,618
2023-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−1,088 sh	$0.88	−$954.72	287,530
2023-02-27	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−6,677 sh	$0.81	−$5,429.736	300,564
2022-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−6,873 sh	$2.17	−$14.9K	308,875
2022-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−6,556 sh	$2.17	−$14.2K	302,319
2022-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−1,078 sh	$2.17	−$2,340.015	304,241
2022-02-28	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−6,555 sh	$2.15	−$14.1K	265,748
2022-02-28	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Legal Officer	AAward	+50K sh	—	—	315,748
2022-02-28	AKBAAkebia Therapeutics, Inc. · Employee Stock Option (Right to buy)A Award	SVP, Chief Legal Officer	AAward	+200K sh	—	—	200,000
2021-04-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−1,060 sh	$3.40	−$3,604	272,303
2021-03-16	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Legal Officer	AAward	+10.2K sh	—	—	273,363
2021-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−6,309 sh	$3.40	−$21.4K	271,147
2021-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−7,976 sh	$3.40	−$27.1K	263,171
2021-02-26	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Legal Officer	AAward	+62K sh	—	—	277,456
2021-02-26	AKBAAkebia Therapeutics, Inc. · Employee Stock Option (Right to buy)A Award	SVP, Chief Legal Officer	AAward	+110K sh	—	—	110,000
2020-02-28	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Legal Officer	AAward	+62K sh	—	—	219,806
2020-02-28	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−7,050 sh	$8.70	−$61.3K	212,756
2020-02-28	AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award	SVP, Chief Legal Officer	AAward	+105K sh	—	—	105,000
2019-04-11	AKBAAkebia Therapeutics, Inc.D Disposition to Issuer	SVP, Chief Legal Officer	DDisposition to Issuer	−11.9K sh	$7.70	−$91.9K	154,806
2019-02-28	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Legal Officer	AAward	+65K sh	—	—	166,735
2019-02-28	AKBAAkebia Therapeutics, Inc. · Employee Stock Option (Right to buy)A Award	SVP, Chief Legal Officer	AAward	+100K sh	—	—	100,000
2018-12-12	AKBAAkebia Therapeutics, Inc.F Tax Payment	SVP, Chief Legal Officer	FTax Payment	−20.2K sh	$8.94	−$180K	101,284
2018-02-28	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Legal Officer	AAward	+17.5K sh	—	—	120,078
2018-02-28	AKBAAkebia Therapeutics, Inc. · Employee Stock Option (Right to buy)A Award	SVP, Chief Legal Officer	AAward	+25K sh	—	—	25,000
2017-10-02	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−1,553 sh	$19.64	−$30.5K	108,054
2017-10-02	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−6,250 sh	$19.95	−$125K	101,804
2017-07-03	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−1,554 sh	$14.26	−$22.2K	109,607
2017-04-03	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−1,556 sh	$9.18	−$14.3K	109,856
2017-02-21	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Legal Officer	AAward	+28.5K sh	—	—	111,412
2017-02-21	AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award	SVP, Chief Legal Officer	AAward	+45K sh	$10.14	+$456K	45,000
2017-01-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−1,810 sh	$10.49	−$19K	82,912
2016-10-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−1,556 sh	$8.95	−$13.9K	83,915
2016-07-05	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−1,557 sh	$7.47	−$11.6K	85,471
2016-04-04	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−1,556 sh	$9.41	−$14.6K	85,528
2016-02-22	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Legal Officer	AAward	+22.5K sh	—	—	87,084
2016-02-22	AKBAAkebia Therapeutics, Inc. · Stock Option (Right to Buy)A Award	SVP, Chief Legal Officer	AAward	+34.3K sh	—	—	34,300
2016-01-04	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−1,811 sh	$12.28	−$22.2K	64,584
2015-10-02	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−1,484 sh	$8.67	−$12.9K	65,260
2015-07-02	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−1,484 sh	$9.54	−$14.2K	66,744
2015-04-02	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Legal Officer	SSale	−1,483 sh	$9.09	−$13.5K	67,015

Recent filings

Accepted (ET)
May 144
Hadas Nicole R.0001562180-24-004026
SEC(opens sec.gov)
Mar 14
Hadas Nicole R.0001562180-24-002022
SEC(opens sec.gov)
Feb 294
Hadas Nicole R.0001562180-24-001995
SEC(opens sec.gov)
Feb 24
Hadas Nicole R.0001562180-24-000973
SEC(opens sec.gov)
May 254
Hadas Nicole R.0001562180-23-004504
SEC(opens sec.gov)
May 164
Hadas Nicole R.0001562180-23-004169
SEC(opens sec.gov)
Mar 34
Hadas Nicole R.0001562180-23-002200
SEC(opens sec.gov)
Mar 14
Hadas Nicole R.0001562180-23-002037
SEC(opens sec.gov)
Mar 24
Hadas Nicole R.0001562180-22-002161
SEC(opens sec.gov)
Apr 14
Hadas Nicole R.0001562180-21-002542
SEC(opens sec.gov)

Companies

Akebia Therapeutics, Inc.SVP, Chief Legal OfficerAKBA

Address

C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET, SUITE 1100

CAMBRIDGE, MA, 02142